Wendy future of retail top

JC Scott

PCMA applauds Biden Administration action to stop drug manufacturer patent abuses

PCMA applauds Biden Administration action to stop drug manufacturer patent abuses

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Biden Administration’s announcement to curb drug manufacturer patent abuses. “We applaud the Biden Administration for taking real action to reduce prescription drug costs. Drug manufacturer pricing strategies that include patent thickets on certain brand drugs unfairly protect

PBMs committed to building a more equitable health care system

PBMs committed to building a more equitable health care system

WASHINGTON — Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on a new report by the U.S. Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE), Office of Health Policy, showing that minorities in Medicare are the most likely to experience prescription drug affordability problems. “The Administration’s research on

PCMA announces PBM industry principles

PCMA announces PBM industry principles

WASHINGTON — The Pharmaceutical Care Management Association (PCMA)  announced on Tuesday a set of industry principles that outline how pharmacy benefit managers, PBMs, interact with employer clients and other prescription drug coverage sponsors to provide clear, transparent contracting and deliver affordable pharmacy benefits. “These principles reinforce the industry’s commitment to PBM interactions that empower employers and

PCMA applauds congressional action to boost use of biosimilars

PCMA applauds congressional action to boost use of biosimilars

WASHINGTON — Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on legislation passed by Congress to increase access to biosimilars, “The Ensuring Innovation Act”  and the “Advancing Education on Biosimilars Act of 2021.” “We applaud Congress for recognizing the need to increase competition in the prescription drug marketplace, especially for

PCMA issues statement on 2020 election results

PCMA issues statement on 2020 election results

WASHINGTON — PCMA president and CEO JC Scott issued the following statement on the 2020 presidential election: “The Pharmaceutical Care Management Association, representing America’s pharmacy benefit managers (PBMs) congratulates the President-elect and looks forward to working with the new Administration on lowering prescription drug costs for all Americans. “We appreciate the stated focus of the

PBMs: The only entity reducing Rx costs on behalf of patients

PBMs: The only entity reducing Rx costs on behalf of patients

WASHINGTON — Pharmaceutical Care Management Association president and CEO JC Scott issued the following statement on today’s hearing in the House Committee on Oversight and Reform on pricing practices for prescription drugs: “We appreciate the House Oversight Committee keeping a spotlight on drug manufacturers’ pricing practices. While drug manufacturers are solely responsible for setting and

PCMA issues statement on the ‘counteroffer’ by drug companies to the administration

PCMA issues statement on the ‘counteroffer’ by drug companies to the administration

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the reported “counteroffer” by the pharma lobby to the Administration: “While we remain deeply engaged in seeking solutions to lower drug prices and are as eager as anyone to see more progress, as reported, the ‘counteroffer’ that has

PCMA launches next phase of ad campaign

PCMA launches next phase of ad campaign

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the launch of the next series of ads as part of the TV and digital advertising campaign on the Administration’s plans to revive the so-called rebate rule. View the new TV ad. “President Trump made the right decision last year to protect America’s seniors by withdrawing

PCMA applauds Maryland for enacting Rx drug price transparency legislation

PCMA applauds Maryland for enacting Rx drug price transparency legislation

WASHINGTON — The Pharmaceutical Care Management Association (PCMA)  issued on Friday the following statement applauding the Maryland legislature and Governor Larry Hogan for enacting first-of-its-kind legislation, HB 978/SB 915, to increase transparency in the prescription drug supply chain. The legislation, sponsored by Delegate Ariana Kelly and Senator Benjamin Kramer, will give Maryland policymakers and the

America’s prescription drug supply chain stands together

America’s prescription drug supply chain stands together

WASHINGTON —  On Thursday, members of the prescription drug supply and payment chain, including pharmacy benefit managers (PBMs), pharmaceutical manufacturers, pharmacies, including specialty and managed care pharmacies, and health plans, sent a letter to Vice President Mike Pence and congressional leaders affirming the safety and resiliency of the drug supply chain, and calling for public-private

PCMA files brief in Rutledge versus PCMA

PCMA files brief in Rutledge versus PCMA

WASHINGTON — On Wednesday, the Pharmaceutical Care Management Association (PCMA) filed its brief with the U.S. Supreme Court in the case of Rutledge versus PCMA, arguing that a misguided Arkansas law creates inefficiencies in employer-sponsored health plans and threatens access to prescription drugs. The brief comes in advance of anticipated oral arguments next month. Unique state

PCMA names new staff addition to state affairs

PCMA names new staff addition to state affairs

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) has announced that Regina Stivers as PCMA’s newest staff addition. Stivers joins PCMA as director, state affairs. She brings a tremendous amount of experience, having worked in both federal and state government and in the private sector overseeing economic development. Before joining PCMA, Regina served as both

New research: PBMs save $962 per person annually

New research: PBMs save $962 per person annually

WASHINGTON — Pharmacy benefit managers (PBMs) save consumers and payers an average of $962 per person per year, according to a new analysis by Visante, a $21 increase from 2016. The research also highlights PBMs’ role in reducing medication errors and improving patients’ health through increased adherence rates and specialty pharmacies. “As prescription drug prices

Study: PBM care management programs improve health outcomes

Study: PBM care management programs improve health outcomes

WASHINGTON — As prescription drug spending is poised to reach as much as $5 trillion during the next decade, new data find that pharmacy benefit managers’ (PBMs’) proven cost savings and patient care management tools should reduce prescription drug costs for health plan sponsors and consumers by an average of 20%, or more than $1

PP_1170x120_10-25-21